Orlistat ≥97%

Supplier: Enzo Life Sciences

Synonyms: N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]methyl]dodecyl Ester(S)-(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-methylpentanoate

350-152-M050 350-152-M250
89149-184EA 68.16 USD
89149-184 89149-186
Orlistat ≥97%
Orlistat

Fatty acid synthase inhibitor


Cell permeable, irreversible inhibitor of gastric and pancreatic lipases. Shows only minimal activity against amylase, trypsin, chymotrypsin, or phospholipase A2 (PLA2). Partially inhibits the hydrolysis of triglycerides and lowers the absorption of dietary fat and promotes weight loss. Anti-obesity drug. Exhibits antitumor activity by inhibition of the thioesterase domain of fatty acid synthase (FAS) both in vitro and in vivo.


Synthetic. Originally isolated from Streptomyces sp.

Formula: C₂₉H₅₃NO₅
MW: 495.75 g/mol
MDL Number: MFCD05662360
CAS Number: 96829-58-2
https://us.vwr.com/stibo/web/std.lang.all/76/90/45347690.jpg

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR